CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • GNLX Dashboard
  • Filings
  • Insider
  • News
  • Patents
  • Reddit

Genelux (GNLX)

Company Profile

Company profile

Ticker
GNLX
Exchange
NASDAQ
Employees
Incorporated
Delaware
Location
California
Fiscal year end
Dec 31
Industry (SIC)
Pharmaceutical Preparations
Pfizer • Johnson & Johnson • Merck & Co • Abbott Laboratories • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Celgene ...
SEC CIK
0001231457
Corporate docs
Underwriting Agreements
Indentures
Material Contracts & Credit Agreements

GNLX stock data

Latest filings (excl ownership)
View all
8-K
Departure of Directors or Certain Officers
30 Jan 23
S-8
Registration of securities for employees
26 Jan 23
424B4
Prospectus supplement with pricing info
26 Jan 23
CERT
Certification of approval for exchange listing
26 Jan 23
EFFECT
Notice of effectiveness
26 Jan 23
8-A12B
Registration of securities on exchange
23 Jan 23
FWP
Free writing prospectus
13 Jan 23
S-1/A
IPO registration (amended)
9 Jan 23
S-1/A
IPO registration (amended)
23 Dec 22
FWP
Free writing prospectus
4 Nov 22
Latest ownership filings
View all
4
Qian Zhang
31 Jan 23
4
Aladar Szalay
30 Jan 23
4
John Thomas
30 Jan 23
4
Gabe Woodward
30 Jan 23
3
Aladar Szalay
25 Jan 23
3
Mary Mirabelli
25 Jan 23
3
Gabe Woodward
25 Jan 23
3
James L Tyree
25 Jan 23
3
John Thomas
25 Jan 23
3
Sean Ryder
25 Jan 23

Recent insider trades

GNLX insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Jan 23 Gabe Woodward Common Stock Conversion Acquire C Yes No 0 2,798 0.00 2,798
30 Jan 23 Gabe Woodward Common Stock Conversion Acquire C No No 0 3,186 0.00 3,186
30 Jan 23 Gabe Woodward Common Stock Conversion Acquire C Yes No 0 5,378 0.00 5,378
30 Jan 23 Gabe Woodward Series K Preferred Stock Common Stock Conversion Dispose C Yes No 0 6,000 0.00 0
30 Jan 23 Gabe Woodward Series J Preferred Stock Common Stock Conversion Dispose C No No 0 7,000 0.00 0
30 Jan 23 Gabe Woodward Series I Preferred Stock Common Stock Conversion Dispose C Yes No 0 13,000 0.00 0
30 Jan 23 John Thomas Common Stock Conversion Acquire C No No 0 470,000 0.00 470,000
30 Jan 23 John Thomas Series A Preferred Stock Common Stock Conversion Dispose C No No 0 1,410,000 0.00 0
30 Jan 23 Aladar Szalay Common Stock Conversion Acquire C Yes No 0 500,000 0.00 550,000
30 Jan 23 Aladar Szalay Common Stock Conversion Acquire C Yes No 0 500,000 0.00 2,258,760
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro
Here's How Genelux Has Performed Since Its IPO
27 Jan 23
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
27 Jan 23
Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.
Intel, Hasbro, Colgate-Palmolive And Other Big Stocks Moving Lower On Friday
27 Jan 23
U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Friday. Here are some big stocks recording losses in today’s session.
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
27 Jan 23
Reported Late Wednesday, Genelux Corporation Announces Pricing Of $15M Initial Public Offering Of 2.5M Shares Of Common Stock At A Price Of $6/Share
26 Jan 23

Press releases

From Benzinga Pro
Genelux Corporation Announces Pricing of Initial Public Offering
25 Jan 23
WESTLAKE VILLAGE, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation ("Genelux" or "the Company"), a clinical-stage immunotherapy company focused on developing a pipeline of next-generation oncolytic viral
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn